Amazon Pharmacy said on Friday it now offers Novo Nordisk's Wegovy weight-loss pill through insurance plans as well as ...

Objective: To describe a rare single-stage surgical approach for vertebral metastatic pheochromocytoma in a middle-aged adult and review perioperative management strategies. Introduction ...

Background: Proton pump inhibitors (PPIs) are widely prescribed, especially in older adults with multiple comorbidities. However, their long-term use may lead to under-recognized adverse effects, ...

Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...

This paper reports three cases of patients successfully treated with doxazosin, as an alternative to prazosin, for nightmares associated with posttraumatic stress disorder (PTSD). All patients were ...

Amlodipine, a dihydropyridine calcium channel blocker, is widely prescribed for hypertension due to its vasodilatory effects and minimal influence on heart rate. However, rare cases of bradycardia ...

Where does this leave us relative to the use of doxazosin in the treatment of hypertension? First, since ALLHAT was not a placebo-controlled trial, but rather an active-controlled one, the study did ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

(NEXSTAR) — President Donald Trump recently called on the Treasury Department to stop minting new pennies, calling them “wasteful” after the Department of Government Efficiency (DOGE) set its own ...

Please provide your email address to receive an email when new articles are posted on . Treatment with once-weekly semaglutide 7.2 mg conferred a 20.7% weight reduction vs. a 17.5% weight loss with ...

Bagsværd, Denmark, 17 January 2025 – Novo Nordisk today announced headline results from STEP UP, a phase 3b trial in the global STEP programme. STEP UP is a 72-week efficacy and safety trial ...